A novel regulator of Pseudomonas aeruginosa keratitis
铜绿假单胞菌角膜炎的新型调节剂
基本信息
- 批准号:10401830
- 负责人:
- 金额:$ 54.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:Activated-Leukocyte Cell Adhesion MoleculeAddressAffinityAnoikisAnti-Bacterial AgentsAntibacterial ResponseAntibioticsAntibodiesBacteriaBacterial InfectionsBindingCD14 AntigenCD14 geneCD6 antigenCell ProliferationCell SurvivalCell surfaceCellsChemotactic FactorsClinicalContact LensesCorneaDevelopmentDiseaseEconomicsEnvironmentEpithelial CellsExhibitsEyeHomeostasisHumanImmunityInfectionInflammatory ResponseIntegral Membrane ProteinInterleukin-17InvadedKeratitisKnock-outKnockout MiceLigandsMediatingModelingMouse StrainsMusNeutrophil InfiltrationNon-MalignantPainPathogenesisPathway interactionsPeptide HydrolasesPhasePhysiologicalPrevention strategyProductionProphylactic treatmentProteinsProto-Oncogene Proteins c-aktPseudomonas aeruginosaPseudomonas aeruginosa infectionPublishingReagentRecombinantsReportingResearchResistanceRoleSerine ProteaseSignal TransductionSolid NeoplasmSteroidsT cell responseT-LymphocyteTestingTimeTissuesTreatment ProtocolsTumor-infiltrating immune cellsUnited StatesVariantVisionVisitWorkantimicrobialantimicrobial peptidebasebiophysical techniquescell typecorneal epitheliumeffective therapyimmunoregulationmicrobialmutantneoplastic cellneutrophilnon-oncogenicnovelnovel therapeutic interventionnovel therapeuticsoverexpressionrecombinant adenovirusrecruitresponseselective expressionside effectsocialtargeted treatmenttreatment strategyunpublished worksγδ T cells
项目摘要
ABSTRACT
CD6 is a critical regulator of T cells that is present on all T cells including γδ T cells. In our recently
published work, we discovered that CUB-Domain-Containing Protein 1 (CDCP1) is a new and important ligand
of CD6. This new discovery demonstrated a surprising role of CDCP1 in immune regulation. CDCP1 was
originally discovered as an overexpressed transmembrane protein on certain solid tumor cells intrinsically
regulating tumor-cell anoikis resistance. However, the distribution of CDCP1 in the eye and its potential role in
ocular immunity and tissue homeostasis were unknown. In our latest (unpublished) work, we used primary
human and mouse corneal epithelial cells, as well as CDCP1- and CD6-knockout (KO) mice, to demonstrate for
the first time that CDCP1 is highly and selectively expressed on normal corneal epithelial cells among all ocular
cells, and that CDCP1 is critical for controlling P. aeruginosa corneal infection, whose underlying mechanisms
integrally involve CD6-expressing γδ T cells. In this proposed project, we will use unique reagents and models
that we have developed, including CDCP1-KO mice, CD6-KO mice, γδ T cell-deficient mice, CDCP1-KO human
corneal epithelial cells and recombinant CDCP1 proteins, to elucidate both intrinsic and extrinsic mechanisms
by which CDCP1 controls bacterial infection of the cornea. We will also test novel CDCP1-targeted approaches
as new therapeutic strategies for managing P. aeruginosa keratitis. The proposed work is expected to establish
a previously unknown role of CDCP1 in the pathogenesis of P. aeruginosa keratitis, facilitate the development
of new and effective therapies for this painful and blinding disease, and open a new avenue for research on
CDCP1 in corneal immunohomeostasis.
抽象的
CD6是T细胞的关键调节剂,它存在于包括γδT细胞在内的所有T细胞上。在我们最近
发表的工作,我们发现含幼崽的蛋白质1(CDCP1)是一种新的重要配体
CD6。这一新发现表明了CDCP1在免疫调节中的意外作用。 CDCP1是
最初是在某些实体瘤细胞上的过表达的跨膜蛋白发现的
调节肿瘤细胞抗阳性抗性。但是,CDCP1在眼中的分布及其在
眼免疫学和组织稳态尚不清楚。在我们的最新(未发表)作品中,我们使用了主要
人和小鼠角膜上皮细胞,以及Cdcp1和CD6-敲除(KO)小鼠,以证明用于
CDCP1首次在所有眼中高度和选择性地表达在正常的角膜上皮细胞上
细胞,该CDCP1对于控制铜绿假单胞菌角膜感染至关重要,其潜在机制
完全涉及CD6表达γδT细胞。在这个拟议的项目中,我们将使用独特的试剂和模型
我们已经开发了包括CDCP1-KO小鼠,CD6-KO小鼠,γδT细胞缺陷小鼠,CDCP1-KO人
角膜上皮细胞和重组CDCP1蛋白,以阐明内在和外在机制
CDCP1控制着角膜的细菌感染。我们还将测试新颖的CDCP1靶向方法
作为管理铜绿假单胞菌角膜炎的新治疗策略。拟议的工作有望建立
CDCP1在铜绿假单胞菌角膜炎的发病机理中的先前未知的作用,支持发育
针对这种痛苦和盲目疾病的新有效疗法,并为研究开辟了新的途径
角膜免疫异性恋中的CDCP1。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FENG C LIN其他文献
FENG C LIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FENG C LIN', 18)}}的其他基金
Role of CDCP1 in the pathogenesis of autoimmune uveitis
CDCP1在自身免疫性葡萄膜炎发病机制中的作用
- 批准号:
10655755 - 财政年份:2023
- 资助金额:
$ 54.86万 - 项目类别:
Development of a novel antibody-drug conjugate for treating T-cell lymphoma.
开发用于治疗 T 细胞淋巴瘤的新型抗体-药物缀合物。
- 批准号:
10545523 - 财政年份:2022
- 资助金额:
$ 54.86万 - 项目类别:
Development of a new drug for treating autoimmune uveitis
治疗自身免疫性葡萄膜炎新药的研制
- 批准号:
10321980 - 财政年份:2021
- 资助金额:
$ 54.86万 - 项目类别:
New mechanisms by which complementýregulates the pathogenesis of experimental autoimmune uveitis
补体调节实验性自身免疫性葡萄膜炎发病机制的新机制
- 批准号:
10175270 - 财政年份:2021
- 资助金额:
$ 54.86万 - 项目类别:
New mechanisms by which complementýregulates the pathogenesis of experimental autoimmune uveitis
补体调节实验性自身免疫性葡萄膜炎发病机制的新机制
- 批准号:
10397686 - 财政年份:2021
- 资助金额:
$ 54.86万 - 项目类别:
New mechanisms by which complementýregulates the pathogenesis of experimental autoimmune uveitis
补体调节实验性自身免疫性葡萄膜炎发病机制的新机制
- 批准号:
10619536 - 财政年份:2021
- 资助金额:
$ 54.86万 - 项目类别:
A novel regulator of Pseudomonas aeruginosa keratitis
铜绿假单胞菌角膜炎的新型调节剂
- 批准号:
10618396 - 财政年份:2020
- 资助金额:
$ 54.86万 - 项目类别:
A novel regulator of corneal wound healing and Pseudomonas aeruginosa keratitis
角膜伤口愈合和铜绿假单胞菌角膜炎的新型调节剂
- 批准号:
9898378 - 财政年份:2019
- 资助金额:
$ 54.86万 - 项目类别:
A novel regulator of corneal wound healing and Pseudomonas aeruginosa keratitis
角膜伤口愈合和铜绿假单胞菌角膜炎的新型调节剂
- 批准号:
10391450 - 财政年份:2019
- 资助金额:
$ 54.86万 - 项目类别:
A novel regulator of corneal wound healing and Pseudomonas aeruginosa keratitis
角膜伤口愈合和铜绿假单胞菌角膜炎的新型调节剂
- 批准号:
10133084 - 财政年份:2019
- 资助金额:
$ 54.86万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
A novel regulator of Pseudomonas aeruginosa keratitis
铜绿假单胞菌角膜炎的新型调节剂
- 批准号:
10618396 - 财政年份:2020
- 资助金额:
$ 54.86万 - 项目类别:
A novel regulator of corneal wound healing and Pseudomonas aeruginosa keratitis
角膜伤口愈合和铜绿假单胞菌角膜炎的新型调节剂
- 批准号:
9898378 - 财政年份:2019
- 资助金额:
$ 54.86万 - 项目类别:
A novel regulator of corneal wound healing and Pseudomonas aeruginosa keratitis
角膜伤口愈合和铜绿假单胞菌角膜炎的新型调节剂
- 批准号:
10391450 - 财政年份:2019
- 资助金额:
$ 54.86万 - 项目类别:
A novel regulator of corneal wound healing and Pseudomonas aeruginosa keratitis
角膜伤口愈合和铜绿假单胞菌角膜炎的新型调节剂
- 批准号:
10133084 - 财政年份:2019
- 资助金额:
$ 54.86万 - 项目类别:
The role of antigenic strength in the primary and memory responses of pathogen sp
抗原强度在病原体的初级反应和记忆反应中的作用
- 批准号:
8574124 - 财政年份:2013
- 资助金额:
$ 54.86万 - 项目类别: